Correlation Engine 2.0
Clear Search sequence regions

  • apneas (1)
  • case report (1)
  • cohort study (1)
  • humans (1)
  • hypoxemia (1)
  • sleep (1)
  • sleep apnea (14)
  • Sizes of these terms reflect their relevance to your search.

    There is persistent speculation that testosterone therapy (TTh) may induce worsening of obstructive sleep apnea (OSA). As both the incidence of OSA and the use of TTh grow more prevalent, it is important to review the current evidence that supports or refutes this relationship. To review the current literature regarding the relationship between TTh and OSA. A literature search was conducted to identify relevant studies. Search terms included "obstructive sleep apnea" and "testosterone replacement therapy." Titles and abstracts were reviewed for relevance. References from identified articles were searched and included, if appropriate. The association between TTh and OSA was initially described in a 1978 case report of an individual with worsened nighttime apneas during testosterone administration, a trend seen again in subsequent small case series. In the 1990s, a large retrospective analysis and the first randomized controlled trial on the subject revealed no increased incidence of OSA in individuals on TTh. A randomized controlled trial conducted in 2012 provided a possible explanation to the previously reported discrepancies, describing a time-limited effect, wherein measures of OSA were elevated at seven weeks but were not significantly different at 18 weeks after initiation of TTh. A recent cohort study demonstrated an incidence of OSA in individuals on TTh of 16.5% compared with 12.7% in controls. TTh is thought to affect OSA in several ways. Theories that the anabolic effects of testosterone may decrease airway patency or that testosterone alters sleep architecture have been largely disproven. More likely, testosterone plays a role in altering neural response pathways to hypoxemia. TTh likely plays a small role in exacerbating or inducing changes in OSA that may be time limited in nature. Clinicians may choose to exercise caution in prescribing TTh to individuals suffering from severe OSA. Payne K, Lipshultz LI, Hotaling JM, et al. Obstructive Sleep Apnea and Testosterone Therapy. J Sex Med 2021;9:296-303. Copyright © 2020 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.


    Kelly Payne, Larry I Lipshultz, James M Hotaling, Alexander W Pastuszak. Obstructive Sleep Apnea and Testosterone Therapy. Sexual medicine reviews. 2021 Apr;9(2):296-303

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32636155

    View Full Text